(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White to Pale Yellow Solid

Verwenden

FK-506 (F370000) impurity. A new macrolite of thermal rearrangement of the immunosuppressant FK-506.

(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(E/Z)-FK-506 26,28-Allylic Ester RearrangeMent IMpurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	24342	58
ShenZhen H&D Pharmaceutical Technology Co., LTD	+8618627948422	sale@hdimpurity.com	China	3681	58
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28172	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
Guangzhou CATO Research Chemicals Inc.	+86-020-81960175-617 +8615602392859	Intermediate@cato-chem.com	China	6335	58
Moxin Chemicals	+8617320513646	Anna@molcoo.com	China	9713	58
Scinova Biotech(Guangzhou) Co., Ltd.	13268215580	scinova_sales@163.com	China	7025	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736 15347293736	2853117764@qq.com	China	9282	58
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18175	56

---

• [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,16S*,17R*,18S*,20R*,21R*,28aS*]]-
• Tacrolimus Impurity 13 （Positional Isomer ）
• 17,21-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclopentacosine-1,9,22,23(6H,25H)-tetrone, 7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-7,21-dihydroxy-3-(4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-10-(2-propenyl)-, [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,1...
• [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,16S*,17R*,18S*,20R*,21R*,28aS*]]-7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-Hexadecahydro-7,21-dihydroxy-3-(4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-10-(2-propenyl)-7,21-epo
• Tacrolimus Impurity 21
• Tacrolimus Impurity 2
• Tacrolimus Rearrangement Lactone
• 17,21-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclopentacosine-1,9,22,23(6H,25H)-tetrone, 7,8,10,13,14,15,16,17,18,19,20,21,26,27,28,28a-hexadecahydro-7,21-dihydroxy-3-(4-hydroxy-3-methoxycyclohexyl)-16,18-dimethoxy-4,6,12,14,20-pentamethyl-10-(2-propenyl)-, [3R-[3R*(1R*,3R*,4R*),4E,6S*,7S*,10R*,11E,14S*,16S*,17R*,18S*,20R*,21R*,28aS*]]-
• (E/Z)-FK-506 26,28-Allylic Ester Rearrangement Impurity
• (E/Z)-FK-506 26,28-Allylic Ester Rearrangemen
• Tacrolimus Impurity 29
• TACROLIMUS REGIOISOMER / IMPURITY D
• Tacrolimus Impurity 36
• 131944-48-4
• Chiral Reagents, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
• Chiral Reagents
• Impurities
• Intermediates & Fine Chemicals
• Pharmaceuticals